Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.
MIDLAND, Texas--(BUSINESS WIRE)--Permian Resources Corporation (âPermian Resourcesâ or the âCompanyâ) (NYSE: PR) today announced the closing of its previously announced acquisition of certain lease...
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (âPURE,â the âCompanyâ or âweâ), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrob...
SAN FRANCISCO--(BUSINESS WIRE)--PHH Mortgage, one of the largest mortgage servicers in the U.S., and a subsidiary of Onity Group Inc. (NYSE: ONIT), is expanding its partnership with Blend Labs, Inc...
WALTHAM, Mass., June 16, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and ra...
SAN FRANCISCO, June 16, 2025 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)âthe worldâs largest online marketplace for authenticated, resale luxury goodsâon June 13, 2025, paid the remaining $26...
BOULDER, Colo., June 16, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development...
DUBLIN, June 16, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committe...
WALTHAM, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeut...
NEWPORT BEACH, Calif., June 16, 2025 /PRNewswire/ -- Blue Acquisition Corp. (the Company) (Nasdaq: BACCU) announced today the closing of its initial public offering of 20,125,000 units, which inclu...
Fourth Quarter Revenue Totaled $119.2 Million, Representing Year-over-Year Growth of 6% Fourth Quarter GAAP Net Loss of $18.8 Million and GAAP EPS of ($0.18); Fourth Quarter Non-GAAP Adjusted Net I...